Afficher la couverture 'Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes | Brodeur, Sébastien' en grand format
/5

0 avis

Pharmacological treatment profiles in the FACE-BD cohort: Treatment description and complete data for bipolar subtypes

Archive ouverte

Brodeur, Sébastien | Terrisse, Hugo | Pouchon, Arnaud | Godin, Ophelia | Aouizerate, Bruno | Aubin, Valerie | Bellivier, Frank | Belzeaux, Raoul | Bougerol, Thierry | Courtet, Philippe | Dubertret, Caroline | Gard, Sebastien | Haffen, Emmanuel | Henry, Chantal | Leboyer, Marion | Olié, Emilie | Roux, Paul | Samalin, Ludovic | Schwan, Raymund | Etain, Bruno | Bosson, Jean-Luc | Polosan, Mircea

Edité par CCSD ; Elsevier -

International audience. In the current study, we provide the list of pharmacological interventions applied during the one-year follow-up period of the Pharmacological treatment profiles in the FACE-BD cohort study. These data show the treatments used in the new clusters formed in this previous study and also in usual bipolarity subtypes. The proportion of each treatment used during the follow-up was calculated. Days on each treatment were also included in this dataset. The complete clinical and paraclinical data analyzed for clusters and bipolar subtypes were included in this dataset. Socio-demographic self-administered and clinician-administered scales, clinical evaluation during the follow-up, psychiatric and somatic comorbidities, and blood tests are shown in this material.

Suggestions

Du même auteur

Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort✰

Archive ouverte | Brodeur, Sébastien | CCSD

International audience. Background: Despite thorough and validated clinical guidelines based on bipolar disorders subtypes, large pharmacological treatment heterogeneity remains in these patients. There is limited k...

Does BioAge identify accelerated aging in individuals with bipolar disorder? An exploratory study in the FACE‐BD cohort

Archive ouverte | Etain, Bruno | CCSD

International audience. Background: Individuals with bipolar disorders (BD) have an estimated loss of life expectancy around 10-15 years. Several laboratory-measured biomarkers of accelerated aging exist (e.g., telo...

Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders

Archive ouverte | Chouchana, Margot | CCSD

International audience. Monitoring of lamotrigine levels is recommended in epilepsy. However, in bipolar disorders (BD), no study has described the therapeutic range in daily practice and factors being associated to...

Chargement des enrichissements...